文献速递流行病学与生物统计临床试验与 GCP

使用个体化治疗效应评估治疗效应异质性

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity.
PubMed 文献 · Stat Med · 2025-01-01

本文提出以个体化治疗效应为基础评估治疗效应异质性的新方法,采用双重稳健学习器推断反映因果对比的伪结局,实现异质性全局检验、协变量排序和个体化效应估计。模拟研究比较了该方法与多种替代方法,并在一项纳入五项银屑病关节炎III期试验的汇总分析中评估异质性,同时整合WATCH工作流形成分析框架。

要点

  • 双重稳健学习器推断伪结局,用于异质性全局检验、协变量排序和个体化效应估计。
  • 模拟研究比较双重稳健学习器与多种替代及竞争方法。
  • 在五项银屑病关节炎III期试验汇总分析中评估治疗效应异质性。

核心结论

  • 以个体化治疗效应为基础的新方法结合WATCH工作流,为分析治疗效应异质性提供稳健框架,有助于在该挑战性领域做出更明智的决策。

研究设计与样本

  • 方法学论文,采用双重稳健学习器推断反映因果对比的伪结局,通过模拟研究比较该方法与多种替代及竞争方法,并在一项五项III期银屑病关节炎试验的汇总分析中评估治疗效应异质性。

主要发现

  • 伪结局用于实现三个目标:治疗效应异质性的全局检验、基于效应修饰影响对协变量排序、提供个体化治疗效应估计。
  • 模拟研究比较了双重稳健学习器与多种替代及竞争方法。
  • 在五项III期银屑病关节炎试验的汇总分析中评估了治疗效应异质性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Assessing treatment effect heterogeneity (TEH) in clinical trials is crucial, as it provides insights into the variability of treatment responses among patients, influencing key decisions related to drug development. Furthermore, it can lead to personalized medicine by tailoring treatments to individual patient characteristics. This paper introduces novel methodologies for assessing treatment effects using the individualized treatment effect as a basis. To estimate this effect, we use a doubly robust (DR) learner to infer a pseudo-outcome that reflects the causal contrast. This pseudo-outcome is then used to perform three objectives: (1) a global test for heterogeneity, (2) ranking covariates based on their influence on effect modification, and (3) providing estimates of the individualized treatment effect. We compare the DR-learner with various alternatives and competing methods in a simulation study, and also use it to assess heterogeneity in a pooled analysis of five Phase III trials in psoriatic arthritis (PsA). By integrating these methods with the recently proposed Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors (WATCH) workflow, we provide a robust framework for analyzing TEH, offering insights that enable more informed decision-making in this challenging area.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Sechidis K, Zhang C, Sun S, et al. Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity. Stat Med. 2025. PMID: 41309053. doi:10.1002/sim.70324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。